The new frontier of Service Management: from IT to… everything
Take a deep dive into the fast-evolving and multifaceted world of IT management in our latest industry reference report.
DISCLAIMER
Bryan Garnier & Co, registered in France no. 452 605 512 is a MiFID branch of Bryan Garnier & Co Limited (a UK company registered under the number 03034095) and is authorized and regulated by the Financial Conduct Authority and the Autorité des Marchés Financiers (AMF). Registered address: 26 avenue des Champs Elysées, Paris 75008.
This has been prepared solely for informational purposes, and is intended only for use by the designated recipient(s). This information was obtained from sources we believe to be reliable, but its accuracy is not guaranteed. All information is subject to change without notice. This does not constitute a solicitation or offer to buy or sell securities or any other instruments, or a recommendation with respect to any security or instrument mentioned herein. This is not a confirmation of terms of any transaction. No representations are made herein with respect to availability, pricing, or performance. Additional information available on request.
This recording should only be listened to by those persons to whom it is addressed and is not intended to be relied upon by any person without subsequent written confirmation of its contents. If you have received this information in error, please destroy it and delete it from your computer. Any form of reproduction, dissemination, copying, disclosure, modification, distribution and/or publication of this recording is strictly prohibited. Please note that any views or opinions presented in this podcast are solely those of the participants and do not necessarily represent those of Bryan, Garnier & Co. Finally, the recipient should check this source and any attachments for the presence of viruses. Bryan, Garnier & Co accepts no liability for any damage caused by any virus transmitted by this communication.
Green hydrogen
Find out more about how green hydrogen is helping to fight climate change and reduce environmental degradation.
DISCLAIMER
Bryan Garnier & Co, registered in France no. 452 605 512 is a MiFID branch of Bryan Garnier & Co Limited (a UK company registered under the number 03034095) and is authorized and regulated by the Financial Conduct Authority and the Autorité des Marchés Financiers (AMF). Registered address: 26 avenue des Champs Elysées, Paris 75008.
This has been prepared solely for informational purposes, and is intended only for use by the designated recipient(s). This information was obtained from sources we believe to be reliable, but its accuracy is not guaranteed. All information is subject to change without notice. This does not constitute a solicitation or offer to buy or sell securities or any other instruments, or a recommendation with respect to any security or instrument mentioned herein. This is not a confirmation of terms of any transaction. No representations are made herein with respect to availability, pricing, or performance. Additional information available on request.
This recording should only be listened to by those persons to whom it is addressed and is not intended to be relied upon by any person without subsequent written confirmation of its contents. If you have received this information in error, please destroy it and delete it from your computer. Any form of reproduction, dissemination, copying, disclosure, modification, distribution and/or publication of this recording is strictly prohibited. Please note that any views or opinions presented in this podcast are solely those of the participants and do not necessarily represent those of Bryan, Garnier & Co. Finally, the recipient should check this source and any attachments for the presence of viruses. Bryan, Garnier & Co accepts no liability for any damage caused by any virus transmitted by this communication.
Beyond IT Service Management
IT management is as old as IT itself. However, it has become a genuine market for software vendors since the 1980s/90s with the wave of client-server architectures that accompanied the installation of PCs and open systems (Unix, Windows, Linux) in companies, as well as software independent of hardware providers. With the loosening of hardware manufacturers’ hold over software and services, IT departments found themselves confronted with rising problems of managing their hardware and software assets, as well as IT operations and services. In response, IT departments put in place standard workflows and specific databases in order to manage their service to internal IT users and to handle and resolve IT-related incidents and problems. With the advent and ramp-up of cloud architectures, these problems have become more acute, requiring a new generation of software tools – primarily delivered as software as a service (SaaS) – for managing IT services, assets, operations and business.
This report will:
- introduce the different segments in IT management software and illustrate use cases, growth drivers, and the competitive landscape;
- explain how IT management software vendors have crossed the line beyond IT, by embracing non-IT domains such as HR or facilities management;
- highlight the issues at stake in customer service management, an area that both offers significant growth opportunities for IT management software and a fiercely competitive environment, with the presence of Salesforce;
- identify the opportunities for consolidation in what is a highly fragmented market.
Download report
Please complete the form below to receive a download link.
Christophe Alleman, former Head of Small and Mid-Cap Equity and Debt Capital Markets at Société Générale, joins Bryan, Garnier & Co as Co-head of Equity Capital Markets
PARIS, 23 February 2021 – Bryan, Garnier & Co, a leading pan-European investment bank focusing on growth companies, is delighted to announce that it has appointed Christophe Alleman as Co-head of Equity Capital Markets.
Based in Paris, Christophe will take up his role to help further expand Bryan, Garnier & Co’s Equity Capital Markets business.
Christophe has a distinguished career in the investment banking industry with a 25-year career at Société Générale. After 10 years in tech M&A, he developed the bank’s franchises in both SME ECM and DCM, helping the businesses to reach market leadership positions. Before leaving Société Générale, Christophe headed the Small and Mid-Cap Equity and Debt Capital Markets and led more than 100 public offerings in Europe across multiple industry verticals. In tech, healthcare and business services, Christophe advised clients such as Altran, Axway, Criteo, DBV Technologies, Illiad, Ingenico, Korian, Orpea Soitec and SopraSteria.
Greg Revenu, Co-founder & Managing Partner states: “Serving our clients throughout their lifecycle and across their capital structure with sector focused M&A and capital markets capabilities allow us to establish long-term partnerships with the most promising European companies. As public capital markets are becoming increasingly attractive for growth companies and their shareholders, the arrival of Christophe is another demonstration of the firm commitment to the success of its clients. We are thrilled to have Christophe, a longstanding friend of the firm, joining us in this exciting moment.”
Pierre Kiecolt-Wahl, Partner, ECM, adds: “I am very pleased to welcome Christophe to Bryan, Garnier& Co and to join me in co-heading our Equity Capital Markets franchise. Christophe brings a long and established track-record of ECM success in the French Small and Mid-Cap market, which represents the largest pool of publicly listed small and mid-cap companies in Continental Europe. We believe the outlook is bright for this segment and with Christophe on board, we add further capability and means to deliver leading capital markets outcomes for our clients.”
Christophe Alleman comments: “I am very glad to join Bryan, Garnier & Co at a time when the firm is fully benefiting from positive markets dynamics and its unique positioning towards growth companies. I admire what Bryan, Garnier & Co has achieved and with its sector and product expertise, I am very confident we can drive the ECM business to new heights.”
In his role, Christophe will contribute to strengthening the group’s existing ECM activities with a primary focus on the French-speaking European markets, where he will leverage his long-standing experience in the small- and mid-cap segment alongside Bryan, Garnier & Co’s track record of bringing some of the leading innovative and growth companies to the capital markets.
With more than 60 private and public capital-raising and M&A transactions closed in 2020, Bryan, Garnier & Co benefits from its longstanding leadership in the healthcare, technology, business services and environmental sectors in Europe. Over the past 36 months, Bryan, Garnier & Co has led more than 40 ECM transactions across nine countries, raising over EUR 2.5bn. Recent successes include the IPOs and/or follow-ons for BioNTech (NASDAQ), Mcphy Energy (Euronext Paris), Carbios (Euronext Paris), Azelio (NASDAQ Stockholm), Materialise (NASDAQ), GenSight (Euronext Paris), and Zealand Pharma (Copenhagen), and Medincell (Euronext Paris).
Additional recent transactions include the acquisition of DL Software by TA Associates, the sale of smartTrade to leading software private equity investor Hg Capital, the take-private of ITSM player Easyvista by Eurazeo, capital for circular economy player asgoodasnew, the sale of Specim to Konica Minolta and the sale of BlueBee to Illumina. Over the years, Bryan, Garnier & Co has distinguished itself by backing some of the most disruptive companies in the domain of alternative proteins (Prolupin), green hydrogen (McPhy Energy), cannabis (Canopy Growth), 3D printing (Materialise), blockchain and cryptocurrencies (Bitfury Group), and mRNA biotech (Moderna and BioNTech).
ADCs: revolutionizing cancer treatment
Antibody drug conjugates are revolutionizing cancer treatment and may even help reduce the need for chemotherapy.
Find out more in our new video:
DISCLAIMER
Bryan Garnier & Co, registered in France no. 452 605 512 is a MiFID branch of Bryan Garnier & Co Limited (a UK company registered under the number 03034095) and is authorized and regulated by the Financial Conduct Authority and the Autorité des Marchés Financiers (AMF). Registered address: 26 avenue des Champs Elysées, Paris 75008.
This has been prepared solely for informational purposes, and is intended only for use by the designated recipient(s). This information was obtained from sources we believe to be reliable, but its accuracy is not guaranteed. All information is subject to change without notice. This does not constitute a solicitation or offer to buy or sell securities or any other instruments, or a recommendation with respect to any security or instrument mentioned herein. This is not a confirmation of terms of any transaction. No representations are made herein with respect to availability, pricing, or performance. Additional information available on request.
This recording should only be listened to by those persons to whom it is addressed and is not intended to be relied upon by any person without subsequent written confirmation of its contents. If you have received this information in error, please destroy it and delete it from your computer. Any form of reproduction, dissemination, copying, disclosure, modification, distribution and/or publication of this recording is strictly prohibited. Please note that any views or opinions presented in this podcast are solely those of the participants and do not necessarily represent those of Bryan, Garnier & Co. Finally, the recipient should check this source and any attachments for the presence of viruses. Bryan, Garnier & Co accepts no liability for any damage caused by any virus transmitted by this communication.
A tasty formula
Alternative proteins and clean labelling are driving food industry growth.
Find out why in our new video.
DISCLAIMER
Bryan Garnier & Co, registered in France no. 452 605 512 is a MiFID branch of Bryan Garnier & Co Limited (a UK company registered under the number 03034095) and is authorized and regulated by the Financial Conduct Authority and the Autorité des Marchés Financiers (AMF). Registered address: 26 avenue des Champs Elysées, Paris 75008.
This has been prepared solely for informational purposes, and is intended only for use by the designated recipient(s). This information was obtained from sources we believe to be reliable, but its accuracy is not guaranteed. All information is subject to change without notice. This does not constitute a solicitation or offer to buy or sell securities or any other instruments, or a recommendation with respect to any security or instrument mentioned herein. This is not a confirmation of terms of any transaction. No representations are made herein with respect to availability, pricing, or performance. Additional information available on request.
This recording should only be listened to by those persons to whom it is addressed and is not intended to be relied upon by any person without subsequent written confirmation of its contents. If you have received this information in error, please destroy it and delete it from your computer. Any form of reproduction, dissemination, copying, disclosure, modification, distribution and/or publication of this recording is strictly prohibited. Please note that any views or opinions presented in this podcast are solely those of the participants and do not necessarily represent those of Bryan, Garnier & Co. Finally, the recipient should check this source and any attachments for the presence of viruses. Bryan, Garnier & Co accepts no liability for any damage caused by any virus transmitted by this communication.
Meal kits: Dinner is served!
Our retail & e-commerce analyst Clément Genelot explores the potential of the meal kit market.
Watch our new video on this emerging food trend.
DISCLAIMER
Bryan Garnier & Co, registered in France no. 452 605 512 is a MiFID branch of Bryan Garnier & Co Limited (a UK company registered under the number 03034095) and is authorized and regulated by the Financial Conduct Authority and the Autorité des Marchés Financiers (AMF). Registered address: 26 avenue des Champs Elysées, Paris 75008.
This has been prepared solely for informational purposes, and is intended only for use by the designated recipient(s). This information was obtained from sources we believe to be reliable, but its accuracy is not guaranteed. All information is subject to change without notice. This does not constitute a solicitation or offer to buy or sell securities or any other instruments, or a recommendation with respect to any security or instrument mentioned herein. This is not a confirmation of terms of any transaction. No representations are made herein with respect to availability, pricing, or performance. Additional information available on request.
This recording should only be listened to by those persons to whom it is addressed and is not intended to be relied upon by any person without subsequent written confirmation of its contents. If you have received this information in error, please destroy it and delete it from your computer. Any form of reproduction, dissemination, copying, disclosure, modification, distribution and/or publication of this recording is strictly prohibited. Please note that any views or opinions presented in this podcast are solely those of the participants and do not necessarily represent those of Bryan, Garnier & Co. Finally, the recipient should check this source and any attachments for the presence of viruses. Bryan, Garnier & Co accepts no liability for any damage caused by any virus transmitted by this communication.
Bryan, Garnier & Co is delighted to announce the appointment of Clifford Siegel as Non-Executive Chairman
PARIS, 12 January 2021 – Bryan, Garnier & Co, a leading pan-European Investment Bank focusing on growth companies, is delighted to announce that Clifford Siegel has been appointed as Non-Executive Chairman at the firm.
Based in London, Clifford will take up this new position to help develop Bryan, Garnier & Co’s strategy across Europe and the US.
Clifford, 63, has a distinguished career in the investment banking industry. After starting and running the US business of the Cresvale Group, he joined Jefferies in New York in 1990, before moving to London in 1993 to become the CEO of the group’s international business.
During Clifford’s 18-year tenure, Jefferies International grew from a small team in London to a global business with revenues of over USD 300m and offices in Asia and Europe. After retiring from Jefferies, he later founded and ran the debt capital markets boutique ISM Capital, before selling the business to Stifel Nicolaus Europe in 2016. He retired from his role as Vice-Chairman of Stifel Nicolaus Europe Ltd in the autumn of 2020.
Olivier Garnier, Co-founder & Managing Partner states: “We are delighted to welcome Cliff to Bryan, Garnier & Co. He brings both a wealth of experience in all facets of the banking business that will help us expand our business footprint and support our strategic ambitions”.
Clifford Siegel comments: “I have admired the remarkable success and consistency of Bryan, Garnier & Co for many years. I am delighted to be joining them at a time when, now more than even, there is a need for highly committed investment bankers with outstanding quality standards, deep industry expertise and broad transaction capacities to support growth companies and their shareholders”.
In his capacity, Clifford will contribute to strengthening the group’s corporate development initiatives. This includes strategic acquisitions and alliances following Bryan, Garnier & Co’s recent developments in the Nordics and the US, as well as the expansion of the firm’s activities in complementary areas such as fixed income and debt advisory.
With more than 60 private and public capital-raising and M&A transactions closed in 2020, Bryan, Garnier & Co benefits from its longstanding leadership in the healthcare, technology and environmental sectors in Europe. Recent transactions include the sale of smartTrade to leading software private equity investor Hg Capital, the take-private of ITSM player Easyvista by Eurazeo, capital for circular economy player asgoodasnew, the sale of Specim to Konica Minolta and the sale of BlueBee to Illumina. Over the years, Bryan, Garnier & Co has distinguished itself by backing some of the most disruptive companies in the domain of alternative proteins (Prolupin), green hydrogen (McPhy Energy), cannabis (Canopy Growth), blockchain and cryptocurrencies (Bitfury Group), and mRNA biotech (Moderna and BioNTech).
The consolidation wave in organic retail has begun
Since our September 2019 deep dive into the French organic market, the attractiveness of the market has remained intact and we are still seeing double-digit growth within the sector. General retailers outperformed specialists in organic goods sales in France, and we believe this trend will continue in 2020 as the organic market goes mainstream. Learn everything about the organic retail consolidation wave in our latest white paper.
Game-changing technologies to meet the climate challenge
Concern over the environment is higher than ever. Yet, current data on greenhouse gas emissions relies on delayed, self-reported, and biased estimates. Our latest white paper on climate tech explores the technologies that have improved emissions monitoring, potentially enabling a reduction in GHG emissions as big as the combined carbon footprint of Germany and France.
Discover our new video: Game-changing technologies to meet the climate challenge
DISCLAIMER
Bryan Garnier & Co, registered in France no. 452 605 512 is a MiFID branch of Bryan Garnier & Co Limited (a UK company registered under the number 03034095) and is authorized and regulated by the Financial Conduct Authority and the Autorité des Marchés Financiers (AMF). Registered address: 26 avenue des Champs Elysées, Paris 75008.
This has been prepared solely for informational purposes, and is intended only for use by the designated recipient(s). This information was obtained from sources we believe to be reliable, but its accuracy is not guaranteed. All information is subject to change without notice. This does not constitute a solicitation or offer to buy or sell securities or any other instruments, or a recommendation with respect to any security or instrument mentioned herein. This is not a confirmation of terms of any transaction. No representations are made herein with respect to availability, pricing, or performance. Additional information available on request.
This recording should only be listened to by those persons to whom it is addressed and is not intended to be relied upon by any person without subsequent written confirmation of its contents. If you have received this information in error, please destroy it and delete it from your computer. Any form of reproduction, dissemination, copying, disclosure, modification, distribution and/or publication of this recording is strictly prohibited. Please note that any views or opinions presented in this podcast are solely those of the participants and do not necessarily represent those of Bryan, Garnier & Co. Finally, the recipient should check this source and any attachments for the presence of viruses. Bryan, Garnier & Co accepts no liability for any damage caused by any virus transmitted by this communication.